BioSpace News Archive

Newron to present at the 31st European Congress of Psychiatry

Newron Pharmaceuticals S.p.A. announced that it will present two e-posters at the 31st European Congress of Psychiatry, taking place on 25-28 March 2023, at the Palais des Congrès of Paris - Place de la Porte Mailot in Paris, France.

March 17, 2023
·
5 min read
Business

VitalHub Announces Q4 and Fiscal Year 2022 Conference Call Date

VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its fiscal and quarter ended December 31st , 2022, after market close on March 23, 2023.

March 17, 2023
·
3 min read
Celyad Oncology to announce full year 2022 financial results and host conference call

Celyad Oncology announced that the Company will report full year 2022 financial and operating results on the evening of Thursday, March 23rd.

March 17, 2023
·
4 min read
Defence Therapeutics Announces Exercise of Warrants for Gross Proceeds of over $5 Million

Defence Therapeutics Inc. (CSE: DTC) (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies

March 17, 2023
·
4 min read
Policy

Aquavit Files Two IND’s For Its Botulinum Toxin With FDA

Announces its IND Submissions to FDA for Aquatox™ at the Annual American Academy of Dermatology 2023

March 17, 2023
·
3 min read
Drug Development

Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC

Pharvaris announced an oral presentation of positive data from its Phase 2 RAPIDe-1 study of PHVS416 for the on-demand treatment of attacks at the 2023 HAEi Regional Conference APAC, taking place in Bangkok, Thailand, on March 17-19, 2023.

March 17, 2023
·
7 min read